These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 4468056)
1. Radioimmunoassay and saturation analysis. Pharmacology. Marks V; Morris BA; Teale JD Br Med Bull; 1974 Jan; 30(1):80-6. PubMed ID: 4468056 [No Abstract] [Full Text] [Related]
2. Radioimmunoassay: its application to drugs of abuse. Harwood CT Pharmacology; 1974; 11(1):52-7. PubMed ID: 4427924 [No Abstract] [Full Text] [Related]
3. [Radio-immunology and toxicology]. Capelle N; Fournier E Eur J Toxicol Environ Hyg; 1974; 7(3):141-6. PubMed ID: 4435049 [No Abstract] [Full Text] [Related]
4. [Radioimmunoassays. Their application in toxicology (author's transl)]. Despaux N; Duprey F; Bohuon C; Boudène C Pathol Biol (Paris); 1976 Jun; 24(6):419-29. PubMed ID: 785347 [TBL] [Abstract][Full Text] [Related]
5. Measurement of therapeutic agents in blood. Marks V; Lindup WE; Baylis EM Adv Clin Chem; 1973; 16():47-109. PubMed ID: 4589494 [No Abstract] [Full Text] [Related]
6. Radioimmunoassays of drugs of abuse in humans: a review. Castro A; Malkus H Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):291-309. PubMed ID: 322225 [TBL] [Abstract][Full Text] [Related]
7. Radioimmunoassay in pharmacology. Labeling of drug antigens. Ly B; Hegesippe M Int J Nucl Med Biol; 1984; 11(1):79-83. PubMed ID: 6376393 [No Abstract] [Full Text] [Related]
8. Radioimmunoassay of cannabinoids in blood and urine. Teale JD; Forman EJ; King LJ; Marks V Lancet; 1974 Sep; 2(7880):553-5. PubMed ID: 4140271 [TBL] [Abstract][Full Text] [Related]
9. The radioimmunoassay of drugs. A review. Landon J; Moffat AC Analyst; 1976 Apr; 101(1201):225-43. PubMed ID: 773213 [No Abstract] [Full Text] [Related]
10. Drugs of abuse radioimmunoassay directory. Spiehler V Clin Toxicol; 1975; 8(2):257-65. PubMed ID: 1149415 [TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassay and related techniques. Kamal S J Pak Med Assoc; 1993 Nov; 43(11):224-5. PubMed ID: 8114257 [No Abstract] [Full Text] [Related]
12. [Determination of drug concentrations in body fluid; possibilities and limitations. II. Determination of plasma levels as a part of individual patient treatment]. Ariëns EJ; Simonis AM Ned Tijdschr Geneeskd; 1980 Jul; 124(29):1201-12. PubMed ID: 6106163 [No Abstract] [Full Text] [Related]
13. Analysis of the major metabolite of delta 9-tetrahydrocannabinol in urine. V. Cross-reactivity of selected compounds in a radioimmunoassay. Jones AB; ElSohly HN; ElSohly MA J Anal Toxicol; 1984; 8(6):252-4. PubMed ID: 6097766 [TBL] [Abstract][Full Text] [Related]
14. Development of radioimmunoassays for drugs. Paxton JW Methods Find Exp Clin Pharmacol; 1981; 3(2):105-17. PubMed ID: 7015040 [No Abstract] [Full Text] [Related]
15. [Methods for determination of cardiac glycosides--possibilities and experiences]. Haustein KO Z Med Lab Diagn; 1979 Apr; 20(2):99-110. PubMed ID: 384698 [No Abstract] [Full Text] [Related]
16. Radioimmunoassay of antibiotics and chemotherapeutic agents. Broughton A; Strong JE Clin Chem; 1976 Jun; 22(6):726-32. PubMed ID: 776448 [TBL] [Abstract][Full Text] [Related]
18. Proceedings: Development of a radioimmunoassay for morphine having minimal cross-reactivity with codeine. Morris BA; Robinson JD; Piall E; Aherne GW; Marks V J Endocrinol; 1975 Jan; 64(1):6P-7P. PubMed ID: 1117229 [No Abstract] [Full Text] [Related]
19. Immunofluorescence detection of drugs in postmortem tissues: a new technique with potential for assessment of drug influence in cause of death. Balkon J; Bidanset JH; Lynch VD J Forensic Sci; 1980 Jan; 25(1):88-94. PubMed ID: 6156225 [TBL] [Abstract][Full Text] [Related]
20. [Cardenolide glycosides. XVI. Studies on the stability of lanatoside C and of the complex of lanatosides ABC in drug forms]. Michalska B; Zurkowska J; Ozarowski A Acta Pol Pharm; 1966; 23(4):325-9. PubMed ID: 5959373 [No Abstract] [Full Text] [Related] [Next] [New Search]